A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2012; you can also visit the original URL.
The file type is
Collaborative Innovation in Drug Discovery
Pharmaceutical companies do not need reminding that drug development has become more difficult: even safe and effective drugs struggle to gain regulatory approval and market access. A new paradigm, whereby R&D and commercial teams collaborate at the beginning of Phase 2 to keep a laser-like focus on stakeholder value, can transform performance.doi:10.1002/9781118778166.ch14 fatcat:3dasnbv2jfgvbmq3v5v735emjq